Genprex to Present and Participate at Upcoming May Investor and Industry Conferences

AUSTIN, Texas, May. 1, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the Company's participation in the following upcoming investor and industry conferences to be held in May 2024.Event: Sidoti Microcap ConferenceConference Dates: May 8-9, 2024Presentation Date: Wednesday, May 8, 2024Presentation Time: 3:15 p.m. ETVenue: VirtualPresenter ...